Thin Film Drug Manufacturing Market Trends, 2016-2024
Global Thin Film Drug Manufacturing Market: Snapshot
The thin film drugs were recorded with high market acceptance due to its ease of application and high effectiveness. Moreover, developed economies such as the U.S. and countries in Europe recorded significant sale of thin film drugs. Thin film drugs achieve the desired therapeutic results. Therefore, they have gained attention in the market as a potential treatment option. According to the research report, the global thin film drug manufacturing market is expected to be worth US$15,984.3 mn by the end of 2024 from US$7,337.8 mn in 2015. During the forecast years of 2016 and 2024, the global market is projected to exhibit a CAGR of 9.0%.
Demand for thin film drugs is increasing globally, leading to considerable research and development activities in the segment. The Journal of Controlled Release 2015 stated the market for oral thin film products exists with around 10 prescription products and around 29 such thin film products under clinical trials. Thus, the thin film drug manufacturing market is anticipated to expand considerably during the forecast period.
Oral Thin Films to Remain Popular due to Ease of Handling
On the basis of product type, the global thin film drug manufacturing market is segmented into oral thin film, transdermal thin film, and others such as ocular thin film among others. The report indicates that the oral thin film segment will be the most promising one as it comes with maximum advantages. These films deliver drugs through the oral mucosa and are known for ease of transportation, skipping the hepatic first pass effect, convenience of handling, and quick onset of action. In light of these benefits, the oral thin film segment is likely to surge at a significant CAGR of 18.3% between 2016 and 2024. Soaring revenue of this segment is attributable to the growing number of clinical trials and higher number of prescription products. On the other hand, the transdermal thin film segment is also poised to emerge with a substantial share in the global market by the end of the forecast period.
North America Emerges as Leading Regional Market
By geography, global thin film drug manufacturing market has been segmented into North America, Europe, Asia Pacific, Latin America, the and Middle East and Africa. In 2016, North America and Europe accounted for the largest share of the thin film drug manufacturing market. The U.S. dominated the thin film drug manufacturing market in North America, accounting for around 85.3% share in 2016. This dominance is majorly due factors such technological advancements in pharmaceutical research with rising demand of novel drug delivery. The extensive investments in research and development are also likely to benefit the regional market. However, Europe is saturated and growing at slow steady rate while Asia Pacific is anticipated to witness the fast growth during the forecast period with major contribution of countries such as India, Japan and China. New product launches with broaden applications, favorable regulations, and growing awareness are likely to drive the market in Asia Pacific during the forecast period.
Some of the key players in the global thin film drug manufacturing market are Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp. The global thin film drug manufacturing market is dominated only by few players, which makes the competitive landscape highly consolidated.
The global thin film drug manufacturing market is segmented as follows:
|
by Product Type |
|
|
by Disease Indication |
|
|
by Geography |
|
Thin film drug manufacturing market is projected to reach US$ 15.984 billion by 2024
Thin film drug manufacturing market is anticipated to expand at a CAGR of 9.0% during the forecast period
Thin film drug manufacturing market is driven by rising demand of novel drug delivery, technological advancements in pharmaceutical research, new product launches with broaden applications, and growing awareness
Oral thin film segment will be the most promising one as it comes with maximum advantages
Top Key players in thin film drug manufacturing market are Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Thin Film Drug Manufacturing Analysis and Forecasts, 2016–2024
4.6. Thin Film Drug Manufacturing - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook
5. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product, 2016–2024
5.4.1. Oral Thin Film
5.4.1.1. Sublingual film
5.4.1.2. Fully dissolving dental/ buccal film
5.4.2. Transdermal Thin Film
5.4.3. Others
5.5. Product Comparison Matrix
5.6. Market Attractiveness By Product
5.7. Oral Thin Film Drugs : Key market insights
5.7.1. Pipeline Analysis
5.7.2. Technology Insights
5.7.3. Key Product Insights
6. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast By Distribution Channel, 2016–2024
6.3.1. Hospital Pharmacies
6.3.2. Drug Stores
6.3.3. Retail Pharmacies
6.3.4. E- Commerce
6.4. Distribution Channel Comparison Matrix
6.5. Market Attractiveness By Distribution Channel
7. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Disease Indication
7.1. Introduction & Definition
7.2. Key Findings
7.3. Key Trends
7.4. Market Value Forecast By Disease Indication, 2016–2024
7.4.1. Schizophrenia
7.4.2. Migraine
7.4.3. Opioid Dependence
7.4.4. Nausea & Vomiting
7.4.5. Others
7.5. Disease Indication Comparison Matrix
7.6. Market Attractiveness By Disease Indication
8. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Region
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Asia Pacific
8.3.4. Europe
8.3.5. Middle East & Africa
8.4. Market Attractiveness By Country/Region
9. North America Thin Film Drug Manufacturing Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast By Product, 2016–2024
9.2.1. Oral Thin Film
9.2.1.1. Sublingual film
9.2.1.2. Fully dissolving dental/ buccal film
9.2.2. Transdermal Thin Film
9.2.3. Others (Ocular Thin Film, etc.)
9.3. Market Value Forecast By Distribution Channel, 2016–2024
9.3.1. Hospital Pharmacies
9.3.2. Drug Stores
9.3.3. Retail Pharmacies
9.3.4. E- Commerce
9.4. Market Value Forecast By Disease Indication, 2016–2024
9.4.1. Schizophrenia
9.4.2. Migraine
9.4.3. Opioid Dependence
9.4.4. Nausea & Vomiting
9.4.5. Others
9.5. Market Value Forecast By Country, 2016–2024
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Distribution Channel
9.6.3. By Disease Indication
9.6.4. By Country
10. Latin America Thin Film Drug Manufacturing Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast By Product, 2016–2024
10.2.1. Oral Thin Film
10.2.1.1. Sublingual film
10.2.1.2. Fully dissolving dental/ buccal film
10.2.2. Transdermal Thin Film
10.2.3. Others (Ocular Thin Film, etc.)
10.3. Market Value Forecast By Distribution Channel, 2016–2024
10.3.1. Hospital Pharmacies
10.3.2. Drug Stores
10.3.3. Retail Pharmacies
10.3.4. E- Commerce
10.4. Market Value Forecast By Disease Indication, 2016–2024
10.4.1. Schizophrenia
10.4.2. Migraine
10.4.3. Opioid Dependence
10.4.4. Nausea & Vomiting
10.4.5. Others
10.5. Market Value Forecast By Country, 2016–2024
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Distribution Channel
10.6.3. By Disease Indication
10.6.4. By Country
11. Asia Pacific Thin Film Drug Manufacturing Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast By Product, 2016–2024
11.2.1. Oral Thin Film
11.2.1.1. Sublingual film
11.2.1.2. Fully dissolving dental/ buccal film
11.2.2. Transdermal Thin Film
11.2.3. Others (Ocular Thin Film, etc.)
11.3. Market Value Forecast By Distribution Channel, 2016–2024
11.3.1. Hospital Pharmacies
11.3.2. Drug Stores
11.3.3. Retail Pharmacies
11.3.4. E- Commerce
11.4. Market Value Forecast By Disease Indication, 2016–2024
11.4.1. Schizophrenia
11.4.2. Migraine
11.4.3. Opioid Dependence
11.4.4. Nausea & Vomiting
11.4.5. Others
11.5. Market Value Forecast By Country, 2016–2024
11.5.1. Japan
11.5.2. India
11.5.3. China
11.5.4. Rest Of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Distribution Channel
11.6.3. By Disease Indication
11.6.4. By Country
12. Europe Thin Film Drug Manufacturing Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast By Product, 2016–2024
12.2.1. Oral Thin Film
12.2.1.1. Sublingual film
12.2.1.2. Fully dissolving dental/ buccal film
12.2.2. Transdermal Thin Film
12.2.3. Others (Ocular Thin Film, etc.)
12.3. Market Value Forecast By Distribution Channel, 2016–2024
12.3.1. Hospital Pharmacies
12.3.2. Drug Stores
12.3.3. Retail Pharmacies
12.3.4. E- Commerce
12.4. Market Value Forecast By Disease Indication, 2016–2024
12.4.1. Schizophrenia
12.4.2. Migraine
12.4.3. Opioid Dependence
12.4.4. Nausea & Vomiting
12.4.5. Others
12.5. Market Value Forecast By Country, 2016–2024
12.5.1. France
12.5.2. Germany
12.5.3. Italy
12.5.4. Spain
12.5.5. Russia
12.5.6. Rest Of Europe
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.6.3. By Disease Indication
12.6.4. By Country
13. Middle East & Africa Thin Film Drug Manufacturing Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast By Product, 2016–2024
13.2.1. Oral Thin Film
13.2.1.1. Sublingual film
13.2.1.2. Fully dissolving dental/ buccal film
13.2.2. Transdermal Thin Film
13.2.3. Others (Ocular Thin Film, etc.)
13.3. Market Value Forecast By Distribution Channel, 2016–2024
13.3.1. Hospital Pharmacies
13.3.2. Drug Stores
13.3.3. Retail Pharmacies
13.3.4. E- Commerce
13.4. Market Value Forecast By Disease Indication, 2016–2024
13.4.1. Schizophrenia
13.4.2. Migraine
13.4.3. Opioid Dependence
13.4.4. Nausea & Vomiting
13.4.5. Others
13.5. Market Value Forecast By Country, 2016–2024
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. UAE
13.5.4. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Distribution Channel
13.6.3. By Disease Indication
13.6.4. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.2.1. ZIM Laboratories Limited
14.2.1.1. Company Details
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Indivior plc.
14.2.2.1. Company Details
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. MonoSol Rx Allergan plc.
14.2.3.1. Company Details
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
14.2.4.1. Company Details
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. IntelGenx Corp
14.2.5.1. Company Details
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Pfizer, Inc.
14.2.6.1. Company Details
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Novartis AG
14.2.7.1. Company Details
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Allergan plc.
14.2.8.1. Company Details
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. NAL Pharma
14.2.9.1. Company Details
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Wolters Kluwer
14.2.10.1. Company Details
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Solvay
14.2.11.1. Company Details
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis
List of Tables
Table 01: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016–2024, by Product Type
Table 02: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016-2024, by Region
Table 03: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
Table 04: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
Table 05: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 06: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 07: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 08: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 11: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 12: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 13: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 14: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 15: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 16: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 17: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 18: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 19: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 20: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 21: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 22: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 23: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 24: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 25: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 26: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 27: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 28: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 29: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 30: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 31: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 32: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel
List of Figures
Figure 01: Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2016–2024
Figure 03: Market Value Share (%), by Disease Indication (2015)
Figure 05: Market Value Share (%), by Region (2015)
Figure 02: Market Value Share (%), by Product Type (2015)
Figure 04: Market Value Share (%), by Distribution Channel (2015)
Figure 06: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Oral Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 08: Global Transdermal Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 09: Global others (ocular thin film, etc.) Market Revenue (US$ Mn), 2014–2024
Figure 10: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2014–2024
Figure 11: Oral Thin Film Drug Manufacturing Market, Pipeline Analysis 2015
Figure 12: Oral Thin Film Drug Manufacturing Market, by Technology
Figure 13: Global Sales of Major OTF Products (US$ Thousand), 2014
Figure 14: Total SUBOXONE Film Sales (US$ Mn), 2010–2014
Figure 15: Total Onsolis & Breakyl Sales (US$ Thousand), 2011–2014
Figure 16: Total Fentanyl Product Sales (US$ Mn), 2010–2014
Figure 17: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 18: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Schizophrenia, 2014–2024
Figure 19: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Migraine, 2014–2024
Figure 20: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Opioid Dependence, 2014–2024
Figure 21: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Nausea & Vomiting, 2014–2024
Figure 22: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Others, 2014–2024
Figure 23: Global Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016-2024
Figure 24: Number of oral thin ?lm drugs by disease indication (out of total identified drugs at different drug development stages), 2015
Figure 25: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 26: Thin Film Drug Manufacturing Market, by Hospital Pharmacies, Revenue (US$ Mn), 2014–2024
Figure 27: Thin Film Drug Manufacturing Market, by Drug Store, Revenue (US$ Mn), 2014–2024
Figure 28: Thin Film Drug Manufacturing Market, by Retail Pharmacies, Revenue (US$ Mn), 2014–2024
Figure 29: Thin Film Drug Manufacturing Market by E-Commerce, Revenue (US$ Mn), 2014–2024
Figure 30: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 31: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Region, 2016 and 2024
Figure 32: North America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 33: Europe Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 34: Latin America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 35: Asia Pacific Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 36: Middle East & Africa Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 37: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Region, 2014–2024
Figure 38: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 39: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 40: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 41: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 42: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 43: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 44: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 45: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 46: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 47: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 48: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 49: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 50: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 51: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 52: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 53: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 54: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 55: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 56: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 57: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 58: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 59: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 60: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 61: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 62: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 63: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 64: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 65: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 66: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 67: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 68: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 69: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 70: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 71: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 72: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 73: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 74: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 75: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 76: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 77: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 78: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 79: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 80: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 81: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 82: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes